Technology
Health
Medical

LeMaitre Vascular

$27.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.65 (-2.31%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell LMAT and other stocks, options, ETFs, and crypto commission-free!

About

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Read More Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Employees
483
Headquarters
Burlington, Massachusetts
Founded
1983
Market Cap
541.16M
Price-Earnings Ratio
24.68
Dividend Yield
1.18
Average Volume
140.72K
High Today
$28.37
Low Today
$27.50
Open Price
$27.94
Volume
20.17K
52 Week High
$39.00
52 Week Low
$21.79

Collections

Technology
Health
Medical
Medical Devices
Advertising and Marketing
Business Services
US
North America

News

Yahoo FinanceMay 9

Is LeMaitre Vascular Inc A Good Stock To Buy?

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices.

20
Seeking AlphaMay 4

LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q1 2019 Results - Earnings Call Transcript

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2019 Results Conference Call May 1, 2019 5:00 PM ET Company Participants J.J. Pellegrino - CFO George LeMaitre - Chairman and CEO Dave Roberts - President Conference Call Participants Rick Wise - Stifel David Rescott - Canaccord Genuity Joe Munda - First Analysis Mike Petusky - Barrington Research Scott Henry - Roth Capital Operator Welcome to the LeMaitre Vascular First Quarter 2019 Financial Results Conference Call. As a reminder, today's call is being ...

8
Simply Wall StMay 3

Here’s What LeMaitre Vascular, Inc.’s (NASDAQ:LMAT) P/E Ratio Is Telling Us

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today, we’ll introduce the concept of the P/E ratio for those who are learning about investing. We’ll look at LeMaitre Vascular, Inc.’s (NASDAQ:LMAT) P/E ratio and reflect on what it tells us about the company’s share price. Based on the last twelve months, LeMaitre Vascular’s P/E ratio is 22.9. That means that at current prices, buyers pay $22.9 for every $1 in trailing yearly profit...

8

Earnings

$0.17
$0.26
$0.34
$0.43
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 25, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.